SensOre

Dispatch Of Share Purchase Plan Offer Document

SensOre Ltd (ASX:S3N) aims to become the top performing global minerals targeting company through deployment of big data, artificial intelligence (AI)/machine learning technologies and geoscience expertise.


Share Purchase Plan

SensOre Limited (SensOre or the Company) (ASX:S3N) is pleased to announce that it has dispatched its Share Purchase Plan (SPP) offer documentation to all eligible shareholders today in accordance with the details of the SPP offer announced to the ASX on 11 May 2023.

A copy of the Share Purchase Plan offer document setting out the terms and conditions of the offer and a sample Application Form are attached to this announcement.

Indicative SPP timetable*

*The timetable above is indicative only and may be subject to change. The commencement of trading of new shares is subject to confirmation from the ASX

This announcement was approved and authorised for release by the Board of Directors of SensOre Ltd.


Click here for the full ASX Release

This article includes content from SensOre Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.

S3N:AU
The Conversation (0)
BlinkLab

BlinkLab to Participate in the Landmark Monash University Autism/ADHD MAGNET Project

BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”), an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for neurological conditions, is pleased to announce their participation in the landmark MAGNET (Monash Autism & ADHD Genetics and Neurodevelopment) study conducted by Monash University’s School of Psychological Sciences.

Link: https://molecularautism.biomedcentral.com/articles/10.1186/s13229-021-00457-3.

Keep reading...Show less
BlinkLab

Large-Scale Study Validates and Enhances BlinkLab’s Accuracy in Detecting Autism in Children

BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”), an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for autism and other neurological conditions, is excited to announce results from the latest study in autism confirming high-accuracy in detecting autism in children ahead of upcoming FDA registrational study.

Keep reading...Show less
  Spectur Limited

Spectur Awarded Long Term Contract with Transport for NSW

Solar security, sensing and visual AI solutions and platforms company Spectur Limited (ASX: SP3) (Spectur or the Company) is pleased to announce the signing of a three-year contract for $787,428 with Transport for NSW (Contract No: CW2592803), with optional extensions to nine (9) years (Total price – nine year term - $2,632,284).

Keep reading...Show less
TSMC logo with chip.

Tech 5: TSMC Gets US$6.6 Billion Biden Admin Grant, Bitcoin Price Hits New All-time High

Bitcoin reached new levels this week, then paused amid speculation about how high it could go.

Meanwhile, the Biden administration finalized a multibillion-dollar arrangement to bring advanced semiconductor manufacturing back to the US, and a nuclear energy firm backed by Sam Altman announced data center supply deals.

Stay informed on the latest developments in the tech world with the Investing News Network's round-up below.

Keep reading...Show less
BlinkLab

BlinkLab Limited (ASX: BB1) – Trading Halt

Description

The securities of BlinkLab Limited (‘BB1’) will be placed in trading halt at the request of BB1, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Wednesday, 20 November 2024 or when the announcement is released to the market.

Keep reading...Show less

Latest Press Releases

Related News

×